Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-02-23

Clinical Trial Update: Bio-enhanced Curcumin as an Add-on Treatment in Maintaining Remission of Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating bio-enhanced curcumin as an add-on to maintain remission in ulcerative colitis. The current status of the trial is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bio-enhanced Curcumin (curcumin)

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: Ulcerative Colitis | Phase 3 | Status: UNKNOWN